Press Releases

SAN DIEGO and VANCOUVER, British Columbia, Nov. 20, 2019 /PRNewswire/ -- Phoenix Molecular Designs (PhoenixMD), a clinical stage biotechnology company d

NEW YORK, Nov. 20, 2019 /PRNewswire/ -- As part of the award-winning #BeHealthiHer movement, GCI Health and HealthyWomen teamed up with Prevention magazine to conduct a survey examining the rising levels of stress among women today. The overwhelming results are highlighted in the

PLYMOUTH MEETING, Pa., Nov. 20, 2019 /PRNewswire/ -- Harmony Biosciences, LLC (Harmony) announced today that data from two clinical studies evaluating the long-term safety and efficacy, as well as the human abuse potential of WAKIX® (pitolisant), have been published in SLEEP. WAKIX is a first-in-class medication with a novel mechanism of action

WASHINGTON, Nov. 20, 2019 /PRNewswire/ -- Deloitte announced today that Vivien Bonazzi, Ph.D., recently joined its government and public services practice as both a managing director and its chief biomedical data scientist for Deloitte Consulting LLP. In this position, Bonazzi will focus on helping federal agencies utilize data science meth

Dragonfly will use its TriNKET™ platform to develop drug candidates directed to multiple targets for autoimmune disorders, and oncology.  AbbVie receives exclusive options to license a number of Dragonfly's natural killer (NK) cell engager immunotherapies. WALTHAM, Mass., Nov. 20, 2019 /PRNewswire/ -- Dragonfly Therapeutics ("Drag

BRAINTREE, Mass., Nov. 20, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, announced global commercial availability for the four-channel

BOSTON, Nov. 20, 2019 /PRNewswire/ -- Today, leaders from business, health care, education and state government launched a new "Massachusetts Caregiver Coalition," a collaboration that includes businesses from diverse industry sectors working with the state to assess and address the needs of unpaid family caregivers in Massachusetts.

NEW YORK, Nov. 20, 2019 /PRNewswire/ -- Belong.Life, developer of the world's largest social network for cancer patients, caregivers and healthcare providers, announced today that it has partnered with The Breast Health

NEW YORK, Nov. 20, 2019 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO),  announces FDA approval of its contract manufacturer IsoTherapeutics Group LLC (ITG). ITG is now cleared to manufacture the Company's FDA approved non-opioid cancer bone pain drug Strontium-89 Chloride USP. The long-awaited approval of the facility means that this important oncologic pain dr

CLEVELAND, Nov. 20, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in the 2019 Piper Jaffray 31st Annual Healthcare Conference in New York, New York. Scott Drake, President and CEO, will give a presentation at 1:30p.m. Eas